Melissa Gabrielli
Family · San Angelo, TXNPI 1548528110
Payments from drug & device makers
Across 188 payments — averaging $83.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$14K
- Tris Pharma Inc$259
- Lilly USA, LLC$250
- Axsome Therapeutics, Inc.$201
- Abbott$187
- Novo Nordisk$157
- plus $1K from 27 others
What the payments were for
- Speaking & faculty fees$11,55074%
- Travel & lodging$9096%
- Food & beverage$3,22821%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 91 | $13,580 |
| Tris Pharma Inc | 15 | $259 |
| Lilly USA, LLC | 15 | $250 |
| Axsome Therapeutics, Inc. | 9 | $201 |
| Abbott | 4 | $187 |
| Novo Nordisk | 7 | $157 |
| Galderma Laboratories, L.p. | 1 | $119 |
| Mayne Pharma Commercial LLC | 3 | $113 |
| Teva Pharmaceuticals USA, Inc. | 5 | $98 |
| Otsuka America Pharmaceutical, Inc. | 5 | $92 |
| Merz North America, Inc. | 2 | $72 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $61 |
| Pfizer | 3 | $49 |
| Amgen | 2 | $42 |
| Dexcom, Inc. | 2 | $42 |
| Ironshore Pharmaceuticals Inc. | 2 | $39 |
| Boehringer Ingelheim | 2 | $38 |
| Shield Therapeutics Inc | 2 | $35 |
| Corium, LLC | 1 | $25 |
| Idorsia Pharmaceuticals US Inc | 1 | $24 |
| Astellas Pharma US Inc | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Bausch Health US, LLC | 1 | $22 |
| Acella Pharmaceuticals, LLC | 1 | $18 |
| Exeltis, USA Inc. | 1 | $17 |
| GSK | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Noven Therapeutics, LLC | 1 | $13 |
| Mentor Worldwide LLC | 1 | $13 |
| AstraZeneca | 1 | $13 |
| Johnson & Johnson | 1 | $12 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $12 |
| TMS Neurohealth Centers Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,687 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrintellixVortioxetine Hydrobromide | 14 | $12,339 |
| Aripiprazole | 15 | $7,446 |
| Armour ThyroidThyroid,pork | 14 | $1,253 |
| Duloxetine Hcl | 31 | $897 |
| Np ThyroidThyroid,pork | 16 | $726 |
| Bupropion XlBupropion Hcl | 15 | $564 |
| Clonazepam | 54 | $452 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 28 | $436 |
| Tramadol Hcl | 25 | $359 |
| Liothyronine Sodium | 11 | $315 |
| Levothyroxine Sodium | 25 | $257 |
| Quetiapine Fumarate | 15 | $257 |
| Sertraline Hcl | 17 | $247 |
| Alprazolam | 69 | $220 |
| Rosuvastatin Calcium | 24 | $204 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $16 | $12,33914 claims |
| AbbVieArmour Thyroid | $13,580 | $1,25314 claims |
| Acella Pharmaceuticals, LLCNp Thyroid | $18 | $72616 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 15,456 family providers in Texas.
Other family in San Angelo
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
- Linda MercadoHouston$211K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.